These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 27053297)

  • 1. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
    Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
    NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease.
    Oga T; Tsukino M; Hajiro T; Ikeda A; Nishimura K
    Int J Chron Obstruct Pulmon Dis; 2011; 6():521-6. PubMed ID: 22069363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations.
    Motegi T; Jones RC; Ishii T; Hattori K; Kusunoki Y; Furutate R; Yamada K; Gemma A; Kida K
    Int J Chron Obstruct Pulmon Dis; 2013; 8():259-71. PubMed ID: 23754870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ADO index as a predictor of two-year mortality in general practice-based chronic obstructive pulmonary disease cohorts.
    Abu Hussein N; Ter Riet G; Schoenenberger L; Bridevaux PO; Chhajed PN; Fitting JW; Geiser T; Jochmann A; Joos Zellweger L; Kohler M; Maier S; Miedinger D; Schafroth Török S; Scherr A; Siebeling L; Thurnheer R; Tamm M; Puhan MA; Leuppi JD
    Respiration; 2014; 88(3):208-14. PubMed ID: 25115178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease.
    Chen CZ; Ou CY; Yu CH; Yang SC; Chang HY; Hsiue TR
    J Am Geriatr Soc; 2015 Feb; 63(2):244-50. PubMed ID: 25641518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches.
    Morales DR; Flynn R; Zhang J; Trucco E; Quint JK; Zutis K
    Respir Med; 2018 May; 138():150-155. PubMed ID: 29724388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ability of Different Scoring Systems to Predict Mortality in Chronic Obstructive Pulmonary Disease Patients: A Prospective Cohort Study.
    Kim J; Lee CH; Hwang SS; Kim DK; Yoon HI; Lee SH; Kim KU; Kim EK; Kim TH; Lee JH; Oh YM; Lee SD
    Respiration; 2019; 98(6):495-502. PubMed ID: 31665736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.
    Puhan MA; Garcia-Aymerich J; Frey M; ter Riet G; Antó JM; Agustí AG; Gómez FP; Rodríguez-Roisín R; Moons KG; Kessels AG; Held U
    Lancet; 2009 Aug; 374(9691):704-11. PubMed ID: 19716962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.
    Casanova C; Marin JM; Martinez-Gonzalez C; de Lucas-Ramos P; Mir-Viladrich I; Cosio B; Peces-Barba G; Solanes-García I; Agüero R; Feu-Collado N; Calle-Rubio M; Alfageme I; de Diego-Damia A; Irigaray R; Marín M; Balcells E; Llunell A; Galdiz JB; Golpe R; Lacarcel C; Cabrera C; Marin A; Soriano JB; Lopez-Campos JL; Soler-Cataluña JJ; de-Torres JP;
    Chest; 2015 Jul; 148(1):159-168. PubMed ID: 25612228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
    Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index.
    Almagro P; Soriano JB; Cabrera FJ; Boixeda R; Alonso-Ortiz MB; Barreiro B; Diez-Manglano J; Murio C; Heredia JL;
    Chest; 2014 May; 145(5):972-980. PubMed ID: 24077342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the visit frequency and the use of questionnaires and indices for COPD: a national survey from the On-Sint study.
    López Ramírez C; Calero Acuña C; Represas Represas C; Aballe Santos L; Casamor R; Fernández-Villar A; López-Campos JL
    Clin Respir J; 2017 May; 11(3):367-373. PubMed ID: 26149089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
    Lee JY; Chon GR; Rhee CK; Kim DK; Yoon HK; Lee JH; Yoo KH; Lee SH; Lee SY; Kim TE; Kim TH; Park YB; Hwang YI; Kim YS; Jung KS
    J Korean Med Sci; 2016 Apr; 31(4):553-60. PubMed ID: 27051239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Mortality Using Different COPD Risk Assessments - A 12-Year Follow-Up.
    Athlin Å; Giezeman M; Hasselgren M; Montgomery S; Lisspers K; Ställberg B; Janson C; Sundh J
    Int J Chron Obstruct Pulmon Dis; 2021; 16():665-675. PubMed ID: 33758503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort).
    Espantoso-Romero M; Román Rodríguez M; Duarte-Pérez A; Gonzálvez-Rey J; Callejas-Cabanillas PA; Lazic DK; Anta-Agudo B; Torán Monserrat P; Magallon-Botaya R; Gerasimovska Kitanovska B; Lingner H; Assenova RS; Iftode C; Gude-Sampedro F; Clavería A;
    BMC Pulm Med; 2016 Nov; 16(1):143. PubMed ID: 27835945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicomponent indices to predict survival in COPD: the COCOMICS study.
    Marin JM; Alfageme I; Almagro P; Casanova C; Esteban C; Soler-Cataluña JJ; de Torres JP; Martínez-Camblor P; Miravitlles M; Celli BR; Soriano JB
    Eur Respir J; 2013 Aug; 42(2):323-32. PubMed ID: 23222874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
    Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
    Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I
    Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.